pretickt

When does Veracyte report earnings?

Veracyte, Inc. · end-of-day data as of Nov 13, 2026

Veracyte
VCYT · $1.96B
$24.33-1.2%
Nov 13, 2026 · close
$40SepOctNov9:3016:003 months -40.2%Nov 13 · close
▲ 7
  • PT$54.14 +122.5%
  • ConsensusBuy · 14
  • P/E vs own-58.8%
  • P/E vs sector-51.0%
  • FCF yield+8.2%
  • RSI28
  • Sector▲ +15.9%
Neutral
  • Earnings in103d
  • P/E15.8x
  • Support-4.4%
  • Resistance+8.5%
  • Off 52w high-60.1%
  • Volume0.8x
  • Bollingerlower half
  • News0.00
  • Trendsideways
  • 52w range$22–$61
  • ATR+14.5%
  • Off ATH-71.7%
▼ 4
  • Insiders-$2.86M
  • MAs0 of 4
  • MA20×50Death 3d ago
  • MACD-2.50

Updates with the 15-min delayed price. Not a forecast or investment advice.

Veracyte VCYT reports its next earnings on Wednesday, Feb 24, 2027, after the close, an estimated date the company has not confirmed yet. Analysts expect EPS of $0.38 on revenue of $151M. Veracyte beat the EPS estimate in 7 of its last 8 reports, and the stock moved ±21.2% on average the session after. The last report, on Nov 4, 2026: EPS of $0.51 against $0.41 expected and revenue of $152M against $147M; the stock fell 54.3% the next session.

The stock around its reports

⇔⇕$25.46$36.33$47.19$58.06Nov 24Apr 25Sep 25Feb 26Jul 26Dec 26AEEEEEEEEA

Last close $24.33 · -37.4% over 2y · E earnings · D dividend · S split · A analyst rating change

Quarterly results

Q3 FY2026: Revenue +15.1% year over year, free cash flow 25.0% of revenue, operating margin 10.9%.

RevenueFree cash flow
Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Q3 FY2026Sep 30, 2026$152M0.38$37.92M70.6%10.9%20.8%
Q2 FY2026Jun 30, 2026$150M0.31$42.97M72.2%15.3%17.0%
Q1 FY2026Mar 31, 2026$139M0.35$32.25M72.3%17.1%20.6%
Q4 FY2025Dec 31, 2025$141M0.50$48.27M74.4%18.4%29.3%
Q3 FY2025Sep 30, 2025$132M0.24$41.97M69.2%17.4%14.5%
Q2 FY2025Jun 30, 2025$130M-0.01$32.32M69.0%-4.0%-0.8%
Q1 FY2025Mar 31, 2025$114M0.09$3.54M69.5%2.5%6.2%
Q4 FY2024Dec 31, 2024$119M0.06$20.38M66.4%3.5%4.3%